143 related articles for article (PubMed ID: 15735714)
1. An integrated data analysis approach to characterize genes highly expressed in hepatocellular carcinoma.
Patil MA; Chua MS; Pan KH; Lin R; Lih CJ; Cheung ST; Ho C; Li R; Fan ST; Cohen SN; Chen X; So S
Oncogene; 2005 May; 24(23):3737-47. PubMed ID: 15735714
[TBL] [Abstract][Full Text] [Related]
2. Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma.
Patil MA; Gütgemann I; Zhang J; Ho C; Cheung ST; Ginzinger D; Li R; Dykema KJ; So S; Fan ST; Kakar S; Furge KA; Büttner R; Chen X
Carcinogenesis; 2005 Dec; 26(12):2050-7. PubMed ID: 16000397
[TBL] [Abstract][Full Text] [Related]
3. Combined functional genome survey of therapeutic targets for hepatocellular carcinoma.
Satow R; Shitashige M; Kanai Y; Takeshita F; Ojima H; Jigami T; Honda K; Kosuge T; Ochiya T; Hirohashi S; Yamada T
Clin Cancer Res; 2010 May; 16(9):2518-28. PubMed ID: 20388846
[TBL] [Abstract][Full Text] [Related]
4. A transcriptome profile in hepatocellular carcinomas based on integrated analysis of microarray studies.
Wang F; Wang R; Li Q; Qu X; Hao Y; Yang J; Zhao H; Wang Q; Li G; Zhang F; Zhang H; Zhou X; Peng X; Bian Y; Xiao W
Diagn Pathol; 2017 Jan; 12(1):4. PubMed ID: 28086821
[TBL] [Abstract][Full Text] [Related]
5. Gene expression profiling reveals potential biomarkers of human hepatocellular carcinoma.
Jia HL; Ye QH; Qin LX; Budhu A; Forgues M; Chen Y; Liu YK; Sun HC; Wang L; Lu HZ; Shen F; Tang ZY; Wang XW
Clin Cancer Res; 2007 Feb; 13(4):1133-9. PubMed ID: 17317821
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profiling, pathway analysis and subtype classification reveal molecular heterogeneity in hepatocellular carcinoma and suggest subtype specific therapeutic targets.
Agarwal R; Narayan J; Bhattacharyya A; Saraswat M; Tomar AK
Cancer Genet; 2017 Oct; 216-217():37-51. PubMed ID: 29025594
[TBL] [Abstract][Full Text] [Related]
7. Sex-based molecular profiling of hepatitis C virus-related hepatocellular carcinoma.
Takemoto N; Iizuka N; Yamada-Okabe H; Hamada K; Tamesa T; Okada T; Hashimoto K; Sakamoto K; Takashima M; Miyamoto T; Uchimura S; Hamamoto Y; Oka M
Int J Oncol; 2005 Mar; 26(3):673-8. PubMed ID: 15703822
[TBL] [Abstract][Full Text] [Related]
8. Gene expression studies of hepatitis virus-induced woodchuck hepatocellular carcinoma in correlation with human results.
Wang F; Anderson PW; Salem N; Kuang Y; Tennant BC; Lee Z
Int J Oncol; 2007 Jan; 30(1):33-44. PubMed ID: 17143510
[TBL] [Abstract][Full Text] [Related]
9. Cross-species hybridization of woodchuck hepatitis viral infection-induced woodchuck hepatocellular carcinoma using human, rat and mouse oligonucleotide microarrays.
Wang F; Kuang Y; Salem N; Anderson PW; Lee Z
J Gastroenterol Hepatol; 2009 Apr; 24(4):605-17. PubMed ID: 19175833
[TBL] [Abstract][Full Text] [Related]
10. A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis.
Llovet JM; Chen Y; Wurmbach E; Roayaie S; Fiel MI; Schwartz M; Thung SN; Khitrov G; Zhang W; Villanueva A; Battiston C; Mazzaferro V; Bruix J; Waxman S; Friedman SL
Gastroenterology; 2006 Dec; 131(6):1758-67. PubMed ID: 17087938
[TBL] [Abstract][Full Text] [Related]
11. Identification of molecular markers for the oncogenic differentiation of hepatocellular carcinoma.
Yu GR; Kim SH; Park SH; Cui XD; Xu DY; Yu HC; Cho BH; Yeom YI; Kim SS; Kim SB; Chu IS; Kim DG
Exp Mol Med; 2007 Oct; 39(5):641-52. PubMed ID: 18059140
[TBL] [Abstract][Full Text] [Related]
12. Identification of hepatocellular carcinoma-associated hub genes and pathways by integrated microarray analysis.
Liu F; Li H; Chang H; Wang J; Lu J
Tumori; 2015; 101(2):206-14. PubMed ID: 25768320
[TBL] [Abstract][Full Text] [Related]
13. Central genetic alterations common to all HCV-positive, HBV-positive and non-B, non-C hepatocellular carcinoma: a new approach to identify novel tumor markers.
Kurokawa Y; Honma K; Takemasa I; Nakamori S; Kita-Matsuo H; Motoori M; Nagano H; Dono K; Ochiya T; Monden M; Kato K
Int J Oncol; 2006 Feb; 28(2):383-91. PubMed ID: 16391793
[TBL] [Abstract][Full Text] [Related]
14. Analysis of differentially expressed genes in human hepatocellular carcinoma using suppression subtractive hybridization.
Miyasaka Y; Enomoto N; Nagayama K; Izumi N; Marumo F; Watanabe M; Sato C
Br J Cancer; 2001 Jul; 85(2):228-34. PubMed ID: 11461082
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.
Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Qiyong L; Fujii T; Sugimoto H; Takeda S; Nakao A
Ann Surg Oncol; 2010 Mar; 17(3):923-32. PubMed ID: 19898900
[TBL] [Abstract][Full Text] [Related]
16. Recurrence and poor prognosis following resection of small hepatitis B-related hepatocellular carcinoma lesions are associated with aberrant tumor expression profiles of glypican 3 and osteopontin.
Yu MC; Lee YS; Lin SE; Wu HY; Chen TC; Lee WC; Chen MF; Tsai CN
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S455-63. PubMed ID: 21822558
[TBL] [Abstract][Full Text] [Related]
17. Hcc-2, a novel mammalian ER thioredoxin that is differentially expressed in hepatocellular carcinoma.
Nissom PM; Lo SL; Lo JC; Ong PF; Lim JW; Ou K; Liang RC; Seow TK; Chung MC
FEBS Lett; 2006 Apr; 580(9):2216-26. PubMed ID: 16574106
[TBL] [Abstract][Full Text] [Related]
18. Genomic analysis reveals RhoC as a potential marker in hepatocellular carcinoma with poor prognosis.
Wang W; Yang LY; Huang GW; Lu WQ; Yang ZL; Yang JQ; Liu HL
Br J Cancer; 2004 Jun; 90(12):2349-55. PubMed ID: 15150600
[TBL] [Abstract][Full Text] [Related]
19. Identification of the A kinase anchor protein 12 (AKAP12) gene as a candidate tumor suppressor of hepatocellular carcinoma.
Hayashi M; Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Yamada S; Fujii T; Sugimoto H; Takeda S; Kodera Y
J Surg Oncol; 2012 Mar; 105(4):381-6. PubMed ID: 22052684
[TBL] [Abstract][Full Text] [Related]
20. Involvement of microRNA-224 in cell proliferation, migration, invasion, and anti-apoptosis in hepatocellular carcinoma.
Zhang Y; Takahashi S; Tasaka A; Yoshima T; Ochi H; Chayama K
J Gastroenterol Hepatol; 2013 Mar; 28(3):565-75. PubMed ID: 22989374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
